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A set of dibenzepinones, dibenzoxepines, and benzosuberones based p38α MAP kinase 
inhibitors [1] was subjected to pharmacophore modeling, molecular docking and in silico ADME 
prediction. This study has been performed to identify the binding pattern and drug likeliness nature 
of these p38α MAP kinase inhibitors. For these compounds, a five point pharmacophore model 
(DDHRR.8) was generated. This model came out to be statistically significant as it had a correlation 
coefficient (R
2
) of 0.98, which was considerably towards higher side, a cross validation coefficient 
(Q
2
) of 0.95 and F value of 330 at 6 component PLS factor. Results of external validation were also 
indicative of high predictive power (R
2
 =0.90). This model also passed Tropsha’s test for predictive 
ability and Y-randomization test. The Domain of Applicability (APD) of the model was also 
successfully defined to ascertain whether the given prediction can be considered reliable or not. 
Further, to determine the effectiveness of docking protocol, co-crystallized ligand was extracted 
from the ligand binding domain of the protein and was re-docked into the same position. The 
conformer obtained on re-docking and the cocrystallized ligand were superimposed. Root mean 
square deviation (RMSD) between the two was found to be 0.548 A°, justifying the efficacy of 
performed docking. Outcomes of this work provide an insight for the development of novel p38α 
MAP kinase inhibitors. 
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